Loeillot Olivier's Form 4 filing
Repligen Corp (RGEN) · filed Nov 26, 2025
- Accession no.
- 0001193125-25-300642
- Filed
- Nov 26, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.20M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loeillot OlivierCIK 0001995525 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | SSaleDisposed | −7,041 | $170.00F1 | −$1,196,970 | 35,898 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 12, 2024.
Referenced by the price of 1 transaction in Table I.